Ashvattha Therapeutics
PrivateLast Round
Series B
Extension
Jan 13, 2025
Total Funding Raised
$149.21M
Company Overview
Ashvattha Therapeutics is a biotechnology company specializing in hydroxyl dendrimer therapeutics aimed at addressing unmet medical needs in oncology, ophthalmology, and inflammatory diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine, Medical Imaging
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Ashvattha Therapeutics Comps
Public and private peers based on sector, stage, and business model.
Ashvattha Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B Extension | Jan 13, 2025 | ||||
| Grant | Sep 1, 2022 | ||||
| Series B | Apr 27, 2022 | ||||
| Series A | Apr 29, 2021 | ||||
| Seed | May 7, 2019 |
Key People
Founding team and executive leadership
Ashvattha Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Natural Capital | Series B, Seed, Series B Extension |
| Tribe Capital | Series B, Seed, Series B Extension |
| National Institute on Aging | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 9, 2026
George Montgomery appointed as new Executive Chairman.
- Oct 15, 2025
Ophthalmology veteran Robert J. Dempsey takes the helm.
Ashvattha Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Ashvattha Therapeutics's valuation, stock price, and market status.
